Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·2d ago
More News
Here's How Much a $1000 Investment in McKesson Made 10 Years Ago Would Be Worth Today
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Zacks·2d ago
McKesson (MCK) Dips More Than Broader Market: What You Should Know
McKesson (MCK) reached $736.52 at the closing of the latest trading day, reflecting a -3.16% change compared to its last close.
Zacks·3d ago
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks·3d ago
McKesson (MCK) Rises Higher Than Market: Key Facts
The latest trading day saw McKesson (MCK) settling at $698.31, representing a +1.19% change from its previous close.
Zacks·9d ago
McKesson (MCK) Outperforms Broader Market: What You Need to Know
The latest trading day saw McKesson (MCK) settling at $719.8, representing a +1.92% change from its previous close.
Zacks·17d ago
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Zacks·17d ago
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks·1mo ago
Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand
COO's Q3 results may top estimates, powered by strong demand for MyDay lenses, Biofinity gains and surgical product resilience despite fertility softness.
Zacks·1mo ago
Cardinal Health to Acquire Solaris Health for Urology Expansion
CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.